• SmD2 Acetylation Drives PARP Inhibitor Sensitivity in HCC

  2026-06-16

  This study uncovers how acetylation-dependent regulation of the spliceosome core protein SmD2 modulates DNA repair and sensitizes hepatocellular carcinoma (HCC) cells to PARP inhibition. The findings reveal a mechanistic link between spliceosome regulation, alternative splicing, and therapeutic vulnerability, suggesting new strategies for targeting DNA repair in BRCA1/2-proficient HCC.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-06-16

  Anlotinib hydrochloride empowers researchers with high-fidelity inhibition of angiogenesis and tumor cell proliferation, outperforming legacy TKIs in both selectivity and safety. Explore advanced experimental workflows, actionable troubleshooting tips, and real-world insights that unlock translational cancer research potential.

• AMG 487: Optimizing CXCR3 Antagonist Workflows in Macrophage

  2026-06-15

  AMG 487, a potent CXCR3 antagonist from APExBIO, enables precise manipulation of macrophage polarization and autophagy states in both inflammatory and non-inflammatory models. This article provides actionable workflows, troubleshooting insights, and data-backed protocol parameters to maximize the value of AMG 487 in chemokine signaling and inflammation research.

• Metabolic Intervention Enhances Ferroptosis and Cuproptosis

  2026-06-15

  This paper describes a nanosystem-based metabolic intervention that simultaneously sensitizes tumor cells to ferroptosis and cuproptosis. By targeting glycolysis and NAD+ metabolism, the approach amplifies regulated cell death and boosts anti-tumor immunity, offering a promising strategy for future cancer therapies.

• G418 Sulfate (Geneticin): Precision Selection and Antiviral

  2026-06-14

  G418 Sulfate (Geneticin) stands apart by enabling both high-stringency genetic selection and robust antiviral assays, uniquely bridging core cell engineering with infectious disease research. Discover protocol-optimized, reproducible workflows and troubleshoot challenges with APExBIO's ultra-pure solution.

• N6-Methyl-dATP: Transforming Epigenetic Research in AML

  2026-06-13

  This article explores how N6-Methyl-dATP, a methylated nucleotide analog from APExBIO, is redefining the landscape of epigenetic and translational research in acute myeloid leukemia (AML). By blending mechanistic insight with strategic guidance, we outline how this molecule empowers researchers to dissect DNA replication fidelity, methylation-driven gene regulation, and the clinical relevance of LMO2/LDB1 complexes. We also benchmark N6-Methyl-dATP against conventional probes, provide protocol parameters for optimal use, and chart next-generation directions for translational workflows.

• MLN4924 HCl Salt: Illuminating Neddylation in Cell Fate Cont

  2026-06-12

  Explore how MLN4924 HCl salt, a potent NEDD8-activating enzyme inhibitor, advances our understanding of the neddylation pathway in regulating cell fate, necroptosis, and immunity. This article uniquely bridges mechanistic insight with experimental design for cancer and viral research.

• p53/PUMA-Dependent Synthetic Lethality by WRN Loss in MSI CR

  2026-06-12

  This study uncovers the mechanism by which depletion or inhibition of Werner (WRN) helicase leads to selective, p53/PUMA-mediated apoptosis in mismatch repair-deficient (MSI) colorectal cancer. The findings reveal a critical vulnerability in p53-wildtype MSI CRCs, supporting WRN as a promising therapeutic target and informing the use of DNA repair enzyme inhibitors in precision oncology.

• 3-Bromopyruvate Induces Ferroptosis to Overcome Cetuximab Re

  2026-06-11

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab induces autophagy-dependent ferroptosis and restores apoptosis in colorectal cancer cells with intrinsic or acquired resistance to cetuximab. The mechanistic insights into FOXO3a/AMPKα/pBeclin1 signaling highlight a promising therapeutic strategy for refractory colorectal cancer.

• Lysis Buffer Advances: Enabling Mouse Genotyping for Modern

  2026-06-11

  Discover how lysis buffer, a key rapid genotyping kit component, accelerates genomic DNA release from mouse tail samples for high-integrity genetic analysis. This article explores technical advances, protocol nuances, and research impacts distinct from existing content.

• Natural Compounds and SARS-CoV-2: Docking Insights for 3CLpr

  2026-06-10

  This study systematically evaluates the repurposing potential of natural vitamin compounds as inhibitors of SARS-CoV-2 main protease (3CLpro) and spike protein RBD using molecular docking and dynamics. The findings highlight key binding interactions, supporting new directions in antiviral therapeutics research focused on viral entry and replication.

• Recombinant Mouse IFN-γ: Precision Control of Antigen Presen

  2026-06-10

  Explore the role of Recombinant Mouse IFN-γ in driving antigen presentation and immune surveillance in metabolic cancer models. This article offers advanced insights into assay design and mechanistic analysis, setting it apart from existing literature.

• Q-VD(OMe)-OPh: Optimizing Caspase Inhibition in Apoptosis Re

  2026-06-09

  Q-VD(OMe)-OPh enables low-toxicity, broad-spectrum caspase inhibition for precise apoptosis modulation across cancer, neuroprotection, and cell differentiation models. This guide translates bench-proven workflows and troubleshooting into practical, reproducible protocols, with evidence-driven insights from recent literature.

• Vitamin D/VDR Drives Endometrial Decidualization via Estroge

  2026-06-09

  This study demonstrates that 1,25-dihydroxy vitamin D3 promotes human endometrial stromal cell (ESC) decidualization through vitamin D receptor (VDR)-dependent regulation of estrogen biosynthesis and signaling. The findings clarify a mechanistic pathway relevant to reproductive health, providing a foundation for targeted infertility research and advancing understanding of the molecular crosstalk between vitamin D and estrogen in the endometrium.

• Anti-ROR1 Antibody (Zilovertamab): Reliable Solutions for Ce

  2026-06-08

  This article provides advanced, scenario-driven guidance for biomedical researchers and lab technicians deploying Anti-ROR1 Antibody (Zilovertamab), SKU F1460, in cell viability and mechanistic assays. Drawing on product data and the latest literature, it details real-world protocol optimizations and vendor selection strategies to maximize reproducibility and experimental clarity. The discussion highlights the unique value of APExBIO's offering in challenging contexts such as Wnt5a-induced ROR1 signaling inhibition and liver injury modeling.

15889 records 4/1060 page Previous Next 12345 下5页 Last page